Single- versus multiple-dose mezlocillin prophylaxis in emergency cesarean section.

Area of Science:

• Obstetrics and Gynecology
• Infectious Diseases
• Pharmacology

Background:

• Postoperative morbidity is a significant concern following cesarean sections.
• Antibiotic prophylaxis is crucial in preventing surgical site infections.

Purpose of the Study:

• To evaluate the efficacy of mezlocillin in reducing postoperative morbidity in emergency cesarean section patients.
• To compare different mezlocillin dosing regimens against a placebo.

Main Methods:

• Prospective, randomized evaluation of 163 patients undergoing emergency cesarean section.
• Comparison of a single preoperative dose of mezlocillin versus a 3-dose perioperative regimen and a placebo.

Main Results:

• Mezlocillin reduced overall postoperative morbidity from 65% (placebo) to 20%.
• Incidences of febrile morbidity, endometritis, and urinary tract infections were significantly lower with mezlocillin.
• No significant difference in morbidity reduction was observed between the two mezlocillin regimens.

Conclusions:

• Mezlocillin prophylaxis is effective in decreasing postoperative morbidity after emergency cesarean sections.
• Benefits include reduced infection rates and shorter hospitalization periods.
• Both evaluated mezlocillin regimens demonstrated comparable efficacy.